The introduction of highly active antiretroviral therapies in the late 1980s and pre-exposure prophylaxis (PrEP) in 2012 changed the trajectory of HIV infection, not only enabling people to live longer, healthier lives, but also lowering transmission rates.
As a result, new HIV infections declined 8% from 2015 to 2019 in the United States, according to the CDC.
Unfortunately, other sexually transmitted infections (STIs) are rising at alarming rates. Once antiretroviral